Lead sponsor
Proclara Biosciences, Inc.
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
83
Total enrollment
23
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's DiseaseAlzheimer's diseasePh 1Completed83